Publication Beamlines Strategic Pillar
琼·塞奥尼苏亚雷斯; 茱蒂特·艾尼多弗古艾拉; 约翰·弗兰松; 让-菲利普·朱利安; 斯威萨·拉曼 et al. (2024). Anti-LIF antibodies and uses thereof. Patent Number: CN118652335A. CMCF-ID Health
琼·塞奥尼苏亚雷斯; 茱蒂特·艾尼多弗古艾拉; 约翰·弗兰松; 让-菲利普·朱利安; 斯威萨·拉曼 et al. (2024). Anti-LIF antibodies and uses thereof. Patent Number: CN111868086B. CMCF-ID Health
スアレス，ジョアン セオアネ; フォルゲイラ，ジュディット アニード; フランソン，ヨハン; ジュリアン，ジャン－フィリペ; ラマン，スウェサ et al. (2022). Antibodies to LIF and their use. Patent Number: JP7100056B2. CMCF-ID Health
Томас ШПРЕТЕР ФОН КРЕДЕНШТАЙН; Сержит Бхимарао ДИКСИТ; Эрик ЭСКОБАР-КАБРЕРА; Пола Ирэн ЛАРИО; Дэвид Кай Юэнь ПУН et al. (2023). DEVELOPMENT OF STABLE HETERODIMERIC ANTIBODY WITH MUTATIONS IN Fc DOMAIN. Patent Number: RU2810540C2. Health
Zimmermann, Elizabeth A.; DeVet, Taylor; Cilla, Myriam; Albiol, Laia; Kavaseri, Kyle et al. (2024). Tissue material properties, whole-bone morphology and mechanical behavior in the Fbn1C1041G/+ mouse model of Marfan syndrome. Matrix Biology Plus 23, 100155. 10.1016/j.mbplus.2024.100155. BMIT-BM Health
Zielinski, M.; Berghuis, A.M. (2021). Erythromycin esterase mutant EreC H289N in its open conformation. Protein Data Bank: 6xcs. CMCF-BM Health
Zhu, Yuao; Yurgelonis, Irina; Noell, Stephen; Yang, Qingyi; Guan, Shunjie et al. (2024). In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance. Science Advances 10(30) . 10.1126/sciadv.adl4013. [PDB: 9aum] CMCF-ID Health
Zhou, Yuebiao; Aliagas, Ignacio; Wang, Shumei; Li, Chun Sing; Liu, Zhiguo et al. (2024). Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosis. Bioorganic and Medicinal Chemistry Letters , 130026. 10.1016/j.bmcl.2024.130026. [PDB: 9dc8, 9dc9] CMCF-BM Health
Zhou, Y.F.; Wei, R.R. (2016). aSMase with zinc. Protein Data Bank: 5i8r. CMCF-ID Health
Zhou, Yan-Feng; Metcalf, Matthew C.; Garman, Scott C.; Edmunds, Tim; Qiu, Huawei et al. (2016). Human acid sphingomyelinase structures provide insight to molecular basis of Niemann–Pick disease. Nature Communications 7(1) . 10.1038/ncomms13082. [PDB: 5i8r] CMCF-ID Health
Zhou, Qun; Jaworski, Julie; Zhou, Yanfeng; Valente, Delphine; Cotton, Joanne et al. (2020). Engineered Fc-glycosylation switch to eliminate antibody effector function. mAbs 12(1) , 1814583. 10.1080/19420862.2020.1814583. [PDB: 6x3i] CMCF-ID Health
Zheng, X.; Ji, N.; Campbell, V.; Slavin, A.; Zhu, X. et al. (2024). Crystal structure of CRBN with compound 3. Protein Data Bank: 9cuo. CMCF-ID Health
Zheng, Xiaozhang; Ji, Nan; Campbell, Veronica; Slavin, Anthony; Zhu, Xiao et al. (2024). Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c01305. [PDB: 9cuo] CMCF-ID Health
Zhao, Jianhua; Beyrakhova, Ksenia; Liu, Yao; Alvarez, Claudia P.; Bueler, Stephanie A. et al. (2017). Molecular basis for the binding and modulation of V-ATPase by a bacterial effector protein. PLoS Pathogens 13(6) , e1006394. 10.1371/journal.ppat.1006394. [PDB: 5uf5, 5ufk] CMCF-BM, CMCF-ID Health
Zhao, Jianhua; Beyrakhova, Ksenia; Liu, Yao; Alvarez, Claudia P.; Bueler, Stephanie A. et al. (2017). Molecular basis for the binding and modulation of V-ATPase by a bacterial effector protein. PLoS Pathogens 13(6) , e1006394. 10.1371/journal.ppat.1006394. [PDB: 5uf5, 5ufk] CMCF-BM, CMCF-ID Health